3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Colonic Cancer: new trials by email Literature Review of Colonic Cancer trials Research Report on Colonic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Palbociclib and Cetuximab in Metastatic Colorectal Cancer Cetuximab, Palbociclib - Cancer of the Colon, Colon Cancer | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 24 | 2018-03-23 | 2026-03-10 |
| EMI-137 in Laparoscopic Colonic Resections EMI-137 - Colonic Cancer, Metastasis to Lymph Node | Phase 2 | Completed | University of Leeds | 10 | 2018-02-14 | 2024-05-08 |
| Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer Oral complex C3 curcumin + chemotherapy, Chemotherapy only - Colonic Cancer, Metastasis | Phase 1 / Phase 2 | Completed | University of Leicester | 41 | 2012-02-01 | 2020-01-31 |
Colonic Neoplasms (3) · Colorectal Neoplasms (1) · Lymphatic Metastasis (1) · Neoplasm Metastasis (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Colorectal Neoplasms (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Neoplasm Metastasis (1) · Rectal Diseases (1)
Cetuximab (1) · Curcumin (1) · Drug Therapy (1) · Folfox protocol (1) · palbociclib (1)
UNC Lineberger Comprehensive Cancer Center (1) · University of Leeds (1) · University of Leicester (1)
United Kingdom (2) · United States (1)
Anne L Thomas, PhD FRCS (1) · Hanna Sanoff (1)
PMID 25872567, PMID 25979230, PMID 26168295, PMID 31132111, PMID 35843546, PMID 36288238, PMID 40990835